Mechanistically, CREB3L1 can promote breast cancer cell invasion and metastasis through inducing ECM production by activating FAK, and a chemical inhibitor of proteases, AEBSF can inhibit breast cancer cell invasion by inhibiting CREB3L1 expression (Feng et al., 2017). Here, PTK2 is linked to breast carcinoma.